Crowley John F

Amicus Therapeutics, Inc.

Executive Chairman, Director

Avg. Two Year Performance

(29%) Avg. Purchase Return (13%) Compound

18% Avg. Sale Return 9% Compound

Holdings: 638.37K shares

Last Three Months: 04-Feb-24 -- 03-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Insider Trading Sentiment: Reduce

Company Sentiment

Biotechnology

Drugs

Two Year Chart

04-May-22 -- 03-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions